These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8878220)

  • 1. Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States.
    Bresee JS; Fischer M; Dowell SF; Johnston BD; Biggs VM; Levine RS; Lingappa JR; Keyserling HL; Petersen KM; Bak JR; Gary HE; Sowell AL; Rubens CE; Anderson LJ
    Pediatr Infect Dis J; 1996 Sep; 15(9):777-82. PubMed ID: 8878220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of respiratory syncytial virus infection with vitamin A: a randomized, placebo-controlled trial in Santiago, Chile.
    Dowell SF; Papic Z; Bresee JS; Larrañaga C; Mendez M; Sowell AL; Gary HE; Anderson LJ; Avendaño LF
    Pediatr Infect Dis J; 1996 Sep; 15(9):782-6. PubMed ID: 8878221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin A and respiratory syncytial virus infection. Serum levels and supplementation trial.
    Quinlan KP; Hayani KC
    Arch Pediatr Adolesc Med; 1996 Jan; 150(1):25-30. PubMed ID: 8542002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy of oral vitamin A supplementation for measles and respiratory syncytial virus (RSV) infection].
    Kawasaki Y; Hosoya M; Katayose M; Suzuki H
    Kansenshogaku Zasshi; 1999 Feb; 73(2):104-9. PubMed ID: 10213986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a single oral dose of 200,000 IU of oil-soluble vitamin A in measles-associated morbidity.
    Rosales FJ; Kjolhede C; Goodman S
    Am J Epidemiol; 1996 Mar; 143(5):413-22. PubMed ID: 8610656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children.
    Rodriguez WJ; Gruber WC; Groothuis JR; Simoes EA; Rosas AJ; Lepow M; Kramer A; Hemming V
    Pediatrics; 1997 Dec; 100(6):937-42. PubMed ID: 9374560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial.
    O'Brien KL; Chandran A; Weatherholtz R; Jafri HS; Griffin MP; Bellamy T; Millar EV; Jensen KM; Harris BS; Reid R; Moulton LH; Losonsky GA; Karron RA; Santosham M;
    Lancet Infect Dis; 2015 Dec; 15(12):1398-408. PubMed ID: 26511956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection.
    Sáez-Llorens X; Moreno MT; Ramilo O; Sánchez PJ; Top FH; Connor EM;
    Pediatr Infect Dis J; 2004 Aug; 23(8):707-12. PubMed ID: 15295219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group.
    Pediatrics; 1997 Jan; 99(1):93-9. PubMed ID: 8989345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
    Rodriguez WJ; Gruber WC; Welliver RC; Groothuis JR; Simoes EA; Meissner HC; Hemming VG; Hall CB; Lepow ML; Rosas AJ; Robertsen C; Kramer AA
    Pediatrics; 1997 Mar; 99(3):454-61. PubMed ID: 9041304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis.
    Piedra PA; Grace S; Jewell A; Spinelli S; Bunting D; Hogerman DA; Malinoski F; Hiatt PW
    Pediatr Infect Dis J; 1996 Jan; 15(1):23-31. PubMed ID: 8684872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth.
    Villamor E; Mbise R; Spiegelman D; Hertzmark E; Fataki M; Peterson KE; Ndossi G; Fawzi WW
    Pediatrics; 2002 Jan; 109(1):E6. PubMed ID: 11773574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children.
    Bisgaard H; Flores-Nunez A; Goh A; Azimi P; Halkas A; Malice MP; Marchal JL; Dass SB; Reiss TF; Knorr BA
    Am J Respir Crit Care Med; 2008 Oct; 178(8):854-60. PubMed ID: 18583576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of massive dose of vitamin A given to preschool children with acute diarrhoea on subsequent respiratory and diarrhoeal morbidity.
    Bhandari N; Bhan MK; Sazawal S
    BMJ; 1994 Nov; 309(6966):1404-7. PubMed ID: 7819847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial of vitamin A as adjuvant treatment for lower respiratory tract infections.
    Kjolhede CL; Chew FJ; Gadomski AM; Marroquin DP
    J Pediatr; 1995 May; 126(5 Pt 1):807-12. PubMed ID: 7752011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
    Romero JR
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled trial of vitamin A in children with severe measles.
    Hussey GD; Klein M
    N Engl J Med; 1990 Jul; 323(3):160-4. PubMed ID: 2194128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants.
    Pediatrics; 1998 Sep; 102(3):531-7. PubMed ID: 9724660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dexamethasone on respiratory syncytial virus-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial.
    Somers CC; Ahmad N; Mejias A; Buckingham SC; Carubelli C; Katz K; Leos N; Gomez AM; DeVincenzo JP; Ramilo O; Jafri HS
    Pediatr Allergy Immunol; 2009 Aug; 20(5):477-85. PubMed ID: 19397752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.